Alzheimer Drug Shows Promise

A losing hand.

Alzheimer’s Treatments Showing Early Promise

https://www.aarp.org/health/brain-health/info-2021/...

Ed1937

This is what I got ...

Identifier org.aarp.everywhere.api.components.modular.layout.FlexibleHeader cannot be correctly instantiated by the Use API

Cannot serve request to /content/aarpe/en/home/health/brain-health/info-2021/....html on this server

Ed1937

Just click on the title, not the address. That will get it for you.

With the several possibilities, we can keep our fingers crossed. Thanks for the link.

2 Young

Great information. DH’s neurologist has been trying to get prior authorization for this one (brand name Nuplazid) but Humana keeps denying the request. 

 Pimavanserin: This antipsychotic drug, already approved to treat hallucinations and delusions in people with Parkinson's disease, is under FDA review for the treatment of some of the behavioral and psychological symptoms of all dementias. “Research shows that it's very effective also in treating dementia-related psychosis or hallucinations,” Sabbagh says. “This is important because these sorts of episodes are the main reason patients with Alzheimer's get placed in memory care facilities. If caregivers can manage these symptoms, more people will be able to stay at home.”